July 13, 2016 article Open access Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients Scientific Reports DOI: 10.1038/srep29506 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 10 stored of 233 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway 2025 International Journal of Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access 1 citations Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer 2024 Prostate Cancer and Prostatic Diseases article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access 3 citations Patients’ experiences with pre-test genetic counseling provided by breast cancer healthcare professionals: Results from a large prospective multicenter study 2023 The Breast article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access 13 citations Surgical Oncologists and Nurses in Breast Cancer Care are Ready to Provide Pre-Test Genetic Counseling 2023 Annals of Surgical Oncology article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access 14 citations Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study 2022 BMC Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access 14 citations Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing 2022 Hereditary Cancer in Clinical Practice article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access 19 citations Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeinschaft Gynäkologische Onkologie intergroup analysis 2022 International Journal of Gynecological Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access 3 citations The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care—A Systematic Review 2022 Cancers review Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access 82 citations Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis 2021 Gynecologic Oncology review Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access 44 citations Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancer 2021 Familial Cancer article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access 31 citations 10 results References 0